Johnson and Johnson 2006 Annual Report Download - page 83

PRINCIPA L O F F ICE
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
[phone]
ANNUA L M E E T I N G
The Annual Meeting of Shareholders will take
place April 26, 2007, at the Hyatt Regency
New Brunswick, 2 Albany Street, New
Brunswick, New Jersey. The meeting will
convene at 10 a.m. All shareholders are
cordially invited to attend. A formal Notice
of Meeting, Proxy Statement and Proxy have
been sent to shareholders.
CO R P O R ATE GOV E RNANCE
Copies of the Company’s 2006 Annual Report
on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K to
the Securities and Exchange Commission,
Proxy Statement, and this Annual Report are
available online at www.jnj.com, or to share-
holders without charge upon written request
to the Secretary at the Company’s principal
address or by calling [phone]
or [phone] (outside the U.S.).
In addition, on the Company’s
Corporate Governance Web site at
www.investor.jnj.com/governance,
shareholders can see the Company’s
Principles of Corporate Governance,
Charters of the Audit Committee,
Compensation & Benefits Committee
and Nominating & Corporate Governance
Committee, Policy on Business Conduct
for employees and Code of Business
Conduct & Ethics for Members of the
Board of Directors and Executive Officers.
Copies of these documents are available to
shareholders without charge upon written
request to the Secretary at the Company’s
principal address.
The Company is required to file as an
Exhibit to its Form 10-K for each fiscal year
certifications under Section 302 of the
Sarbanes-Oxley Act signed by the Chief
Executive Officer and the Chief Financial
Officer. In addition, the Company is required
to submit a certification signed by the Chief
Executive Officer to the New York Stock
Exchange within 30 days following the
Annual Meeting of Shareholders. Copies of
the certifications filed for previous years
are posted on the Company’s Corporate
Governance Web site, and future certifica-
tions will be posted promptly upon filing.
CO M M O N S TOCK
Listed on New York Stock Exchange
Stock Symbol JNJ
SHAREHOLDER RELAT I O N S CONTAC T
Steven M. Rosenberg
Corporate Secretary
[phone]
INVESTOR R E L AT I O N S CONTACT
Louise Mehrotra
Vice President, Investor Relations
[phone]
[phone]
TRANSFER AG E N T A N D REG I S T R A R
Questions regarding stock holdings,
certificate replacement/transfer, dividends
and address changes should be directed to:
Computershare Trust Company, N.A.
250 Royall St.
Canton, MA 02021
[phone] or
[phone] (outside the U.S.)
Internet: www.computershare.com/jnj
“Checkmark-and-tree” logo ©1996 Forest Stewardship Council
DIVIDEND REINVESTM E N T P L A N
The Plan allows for full or partial
dividend reinvestment, and additional
monthly cash investments up to $50,000 per
year, in Johnson & Johnson common stock
without brokerage commissions or service
charges on stock purchases. If you are
interested in participating in the Plan and
need an authorization form and/or more
information, please call Computershare
Trust Company, N.A. at [phone]
or [phone] (outside the U.S.).
HEARING IMPA I RED
Shareholders who have inquiries
regarding stock-related matters can
communicate directly with Computershare
Trust Company, N.A. via a telecommunica-
tions device (TDD). The telephone number
for this service is [phone]
or [phone] (outside the U.S.).
Registered shareholders who wish to receive
electronic notice of online access to future
annual reports and proxy materials instead
of paper copies may register online at
www.econsent.com/jnj.
WEB SITE
www.jnj.com
For more information on
Johnson & Johnson history:
www.kilmerhouse.com
Entire contents
©Johnson & Johnson 2007
C O R P O R A T E A N D S H A R E H O L D E R I N F O R M A T I O N
THE F O LLOWI N G TRADEM A R KS AN D TRADE N A MES OF J O HNSON & JOHNSO N AND IT S AFFI L I AT E D CO M PANIES A PPEAR I N THIS R E PORT:
1-DAY ACUVUE, 1-DAY ACUVUE DEFINE, 1-DAY ACUVUE MOIST, 2-IN-1 WARMING, ACTIVE NATURALS, ACTIVE PHOTOBARRIER COMPLEX, ACUVUE, ACUVUE ADVANCE,
ACUVUE OASYS, ADVANTAGE, ALZA, AMBI, AMBI EVEN & CLEAR, ANGIOGUARD, ANIMAS, AVEENO, AVEENO ULTRA CALMING, BABYCENTER, BAND-AID, BENADRYL,
BIOSENSE WEBSTER, CAREFREE, CARTO, CELLSEARCH, CENTOCOR, CHARITE, CILAG GMBH INTERNATIONAL, CLEAN & CLEAR, COMPEED, CONSTA, CONTOUR
TRANSTAR, CORDIS, CORTAID, CYPHER SELECT, DACOGEN, DEPUY, DEPUY ASR, DEPUY MICROHIP, DEPUY MITEK, DEPUY ORTHOPAEDICS, DEPUY PROXIMA, DISCOVER,
DOXIL, DURAGESIC, E-TRANS, ECHELON 60 ENDOPATH, ENDOPATH ETS, ENDOPATH XCEL, EPREX/ERYPO, ETHICON, ETHICON ENDO-SURGERY, ETHICON OMNEX,
EVOTECH, FLOXIN, GENESEARCH, GOTABS, GROUPE VENDOME, GYNECARE MORCELLEX, GYNECARE TVT SECUR, HARMONIC ACE, HARMONIC WAVE, HELIOPLEX,
INVEGA, IONSYS, JANSSEN-CILAG, JANSSEN PHARMACEUTICAL K.K., JOHNSON & JOHNSON, JOHNSON & JOHNSON PEDIATRIC INSTITUTE, JOHNSON’S, JURNISTA, K-Y,
LABORATORIES VENDOME, LACREON, LE PETIT MARSEILLAIS, LIFESCAN, LIGAMAX, LISTERINE, LUBRIDERM, MAMMOTONE, MCNEIL, MICROTIP, MILAGRO, NATRECOR,
NEOSPORIN, NEUTROGENA, NEUTROGENA MINERAL SHEERS, NICORETTE, ONETOUCH, ONETOUCH HORIZON, ONETOUCH ULTRA, ONETOUCH ULTRAEASY,
ONETOUCH ULTRAMINI, OROS, ORTHO, ORTHO BIOTECH, ORTHO-CLINICAL DIAGNOSTICS, POROCOAT, PRECISE, PREZISTA, PRIM’AGE, PROCRIT/EPREX, QUICK
PACK, REACH, REACH CLEANPASTE, REACH INBETWEEN, REMBRANDT, REMICADE, RISPERDAL, RISPERDAL CONSTA, RISPERDAL M-TAB, SENSUAL MIST, SOFTLOTION,
SOFTWASH, SOOTHING NATURALS, SPLENDA, STAYFREE, SUDAFED, SURGIFLO, TIBOTEC, TOPAMAX, TOUCH MASSAGE, TYLENOL, ULTRAM, ULTRAPRO, VELCADE,
VERIDEX, VIACTIV, VIRCO, VISINE, VISTAKON, VITROS, XIAN-JANSSEN PHARMACEUTICAL, YONDELIS, ZARNESTRA
THE F O LLOWI N G TRADEM A R KS OF OTH E R CO M PANIE S A LSO AP P E AR IN T H IS REP O RT:
ACIPHEX/PARIET (Eisai Co., Ltd.); ACUSON AcuNav (Siemens Medical Solutions); Associado Saude de Familia; China Hospital Management Association;
Chinese Ministry of Health, Division of Child Health; The Conservation Fund; CRESCENDO (ClearStream Techonologies Group, PLC); DACOGEN (MGI Pharma);
Elizabeth Glaser Pediatric AIDS Foundation; Forest Stewardship Council; Glen C. Olsen Hospital (Project Mercy); Green Power Partnership; Healthy
Communities, Healthy Ecosystems (World Wildlife Fund); INSEAD; Kentucky Department of Public Health; LEVAQUIN (Daichi Pharmaceutical Co.); March of
Dimes (Prematurity Prevention); Medhane-Alem School (Project Mercy); The Nature Conservancy; Neonatal Resuscitation Program; REGATTA (Brivant Ltd.);
SAFE KIDS WORLDWIDE; The Trust for Public Land; UCLA Management Development Institute; ULTRAM ER (Biovail Corporation); U.S. Environmental
Protection Agency; VELCADE (Millennium Pharmaceuticals, Inc.); The Wilderness Society; World Wildlife Fund; YONDELIS (PharmaMar)
The paper used in this publication is made from 30% post-con-
sumer recycled fiber, is Forest Stewardship Council® certified
for chain of custody and was manufactured with green energy
credits for purchase of electricity generated from renewable-
energy sources such as wind and low-impact hydro resources.